Evaluation of Sorafenib in Combination With Local Micro-therapy Guided by Gd-EOB-DTPA Enhanced MRI in Patients With Inoperable Hepatocellular Carcinoma

Trial Profile

Evaluation of Sorafenib in Combination With Local Micro-therapy Guided by Gd-EOB-DTPA Enhanced MRI in Patients With Inoperable Hepatocellular Carcinoma

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 29 Mar 2017

At a glance

  • Drugs Sorafenib (Primary) ; Yttrium-90
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Acronyms SORAMIC
  • Most Recent Events

    • 25 Mar 2017 This trial has been completed in Spain.
    • 02 Dec 2016 Status changed from recruiting to active, no longer recruiting.
    • 07 Mar 2016 According to an Otto von media release, enrolment for the palliative care cohort has been completed in this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top